If you're looking for long-term, small-cap speculative disruptors along with IDI, my favorites are: TVIA (next gen food/ingredients), ENOC (energy software/smart grid), PACB (genetic sequencing machines), & IMI (research acceleration/ip). I wouldn't really call it a potential disruptor, but HTM (geothermal plants) is also a small-cap name poised for steady growth.
PACB has gotten a bit too big really to be considered a small-cap anymore, but is still early stage. IMI has fallen well short of its potential but is now slowly recovering & the royalties for its key IP should begin coming in over the next few years, TVIA has never been respected by the market but is poised to make a real difference starting next year. I think ENOC is doing better than most people think, but has choppy financials and it will take some time to land & expand its comprehensive software. HTM is an undervalued no-name with a proven business model that just takes time to unfold now that it is already profitable.
Of course these are just some of my speculative plays using $ allocated for risk.
Insider transactions show that Brauser, serving as the manager of Birch Tree Capital, LLC., bought almost 420,000 more shares at a price of $5.25 on May 18.
I believe that's his largest common share purchase. This was filed today on may 11.
Sure you're a long. Idi core is released in q2 and you hold it accountable for not producing in q1. Let's ignore the fact it hasn't even had a chance to scale yet and you're holding it responsible for not producing before it was launched.....
The company actually had a positive adjusted EBITDA. And no where did it have a 32 million loss. Go cover your position, shorty. This co is poised for growth. Only a dumb trader cares about the stock price over the next year. A real investor knows opportunity when he sees it.
Calm down. It's Amazon's algorithms. Amazon is a distributor and they use proprietary algorithms and numerous iterations before they get the supply/demand balance correct.
Company's predicting $170+ million in revenue for 2016, an 1100% increase in growth yoy, and you're worried about a small possible downturn? I agree you better sell, because you sure aren't the type of investor I want to be on the same side of...